COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00637884
Brief Title: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms

First Submitted : March 10, 2008
First Submitted that Met QC Criteria : March 17, 2008
First Posted : March 18, 2008 (Estimate)

Last Update Submitted that Met QC Criteria : January 10, 2011
Last Update Posted : January 11, 2011 (Estimate)